findmyKOL
Clinical trialNCT01687218CompletedPhase 2Interventional

Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel

SponsorCONRADEnrollment195HIV
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Peru
  • Asociacion Civil Impacta Salud Y Educacion (impacta)

    Lima, Peru

Puerto Rico
  • University of Puerto Rico Medical Sciences Campus - Maternal Infant Studies Center (cemi)

    San Juan, Puerto Rico

South Africa
  • Desmond Tutu Hiv Foundation

    Cape Town, South Africa

Thailand
  • Research Institute for Health Sciences - Chiang Mai University

    Chiang Mai, Thailand

  • Thailand Moph - Us Cdc Collaboration (tuc)

    Nonthaburi, Thailand

United States
  • Hiv Research Section, San Francisco - Department of Public Health

    San Francisco, California, United States

  • the Fenway Institute/fenway Community Health

    Boston, Massachusetts, United States

  • University of Pittsburgh Medical Center (upmc)

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Sept 2013
Primary completion
26 May 2015
Completion
26 May 2015
Last update posted
24 Jun 2021
Registered enrollment
195
Registry id
NCT01687218

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.